IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

XTL Biopharmaceuticals LTD

CUSIP: 98386D307 | 18 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Noked Israel Ltd198,888
0.0% of portfolio›$115
Citadel Advisors LLC75,866
0.0% of portfolio›$44.0K
Rhumbline Advisers30,108
0.0% of portfolio›$17.5K
Gamma Investing LLC12,887
0.0% of portfolio›$7.5K
XTX Topco Ltd10,238
0.0% of portfolio›$5.9K
Morgan Stanley1,740
0.0% of portfolio›$1.0K
StyleTurnoverLocationFiled
Noked Israel Ltd
198,888$1150.0%MomentumHighRamat Hasharon, Luxembourg2026-02-13
Citadel Advisors LLC
75,866$44.0K0.0%CoreVery HighMiami, FL2026-02-17
Rhumbline Advisers
30,108$17.5K0.0%IndexVery LowBoston, MA2026-02-13
Gamma Investing LLC
12,887$7.5K0.0%IndexVery LowFoster City, CA2026-01-05
XTX Topco Ltd
10,238$5.9K0.0%ValueVery HighLondon, United Kingdom2026-02-17
Morgan Stanley
1,740$1.0K0.0%CoreLowNew York, NY2026-05-27